This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-007797-toam6r5y | Middle East respiratory syndrome coronavirus: what does a radiologist need to know? |
| cord-007797-toam6r5y | Pseudomonas aeruginosa predict optimal outcome Imaging infection Imaging of community- acquired pneumonia High resolution CT findings in community- acquired pneumonia Atypical pneumonia Atypical pneumonia-- time to breathe new life into a useful term? |
| cord-000757-bz66g9a0 | R Foundation for Statistical Computing Entity axis codes Documentation of the mortality tape file for Community- acquired pneumonia: can it be defined with claims data? |
| cord-016659-26zz8kaw | What has computed tomography taught us about the acute respiratory distress syndrome? |
| cord-302111-kg0dmgq0 | cause recurrent wheeze of early childhood and asthma? |
| cord-019089-oots4fe4 | Pulmonary cystic echinococcosis Ascariasis and hookworm Viral versus bacterial infections in children: is roentgenographic differentiation possible? |
| cord-019089-oots4fe4 | What imaging should we perform for the diagnosis and management of pulmonary infections? |
| cord-027679-89yt6fzo | the emerging pathologic- radiologic correlates of an emerging disease Radiology of bacterial weapons- old and the new? |
| cord-266516-0ure8256 | Childhood pneumonia: a neglected, climate- sensitive disease? |
| cord-266516-0ure8256 | The Group Health Medical Associates Treatment of RSV pneumonia in adults: evidence of ribavirin effectiveness? |
| cord-015763-5lx179pa | authors: Thellier, D.; Georges, H.; Leroy, O. title: Quels prélèvements aux urgences pour le diagnostic microbiologique d’une infection pulmonaire communautaire grave du sujet immunocompétent? |
| cord-015763-5lx179pa | procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? |
| cord-254874-ug0ler5e | Investment in pneumonia and pneumococcal research Medical subject headings used to search the biomedical literature MeSH now: automatic MeSH indexing at PubMed scale via learning to rank years on-is the NLM medical text indexer still useful and relevant? |
| cord-254874-ug0ler5e | The impact of African science: a bibliometric analysis Differences in citation rates by country of origin for papers published in top- ranked medical journals: do they reflect inequalities in access to publication? |
| cord-001894-ptuelrqj | ICU- Acquired Pneumonia Study Group De- escalation therapy: is it valuable for the management of ventilator- associated pneumonia? |
| cord-007575-5ekgabx5 | Diffuse pneumonia and acute respiratory failure due to infectious mononucleosis Clinical, virologic, and serologic evidence of Epstein- Barr virus infection in association with childhood pneumonia Pneumonia associated with rising cytomegalovirus antibody titres in a healthy adult Does cytomegalovirus playa role in communityacquired pneumonia? |
| cord-028328-5lews3uw | Delayed administration of antibiotics and atypical presentation in community- acquired pneumonia Antibiotics and pneumonia: is timing everything or just a cause of more problems? |
| cord-028328-5lews3uw | Intrapulmonary penetration of linezolid Intrapulmonary pharmacokinetics of linezolid Pneumonia treatment process and quality Quality of care, process, and outcomes in elderly patients with pneumonia Antibiotic timing and diagnostic uncertainty in Medicare patients with pneumonia: is it reasonable to expect all patients to receive antibiotics within 4 hours? |
| cord-028328-5lews3uw | The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens Pneumonia acquired in the community through drug- resistant Streptococcus pneumoniae Multivariate analysis of risk factors for infection due to penicillin- resistant and multidrug- resistant Streptococcus pneumoniae: a multicenter study Methicillin- resistant Staphylococcus aureus: a new communityacquired pathogen? |
| cord-009667-8r8j0h08 | How important is methicillin- resistant Staphylococcus aureus as a cause of community- acquired pneumonia and what is best antimicrobial therapy? |
| cord-009667-8r8j0h08 | How long should we treat community- acquired pneumonia? |
| cord-009667-8r8j0h08 | Reaching stability in community- acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients Early switch to oral treatment in patients with moderate to severe community- acquired pneumonia: a meta- analysis Antimicrobial treatment failures in patients with community- acquired pneumonia: causes and prognostic implications What is the best approach to the nonresponding patient with community- acquired pneumonia? |
| cord-009667-8r8j0h08 | a prospective, controlled clinical evaluation Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community- acquired pneumonia in Spain Is the lateral decubitus radiograph necessary for the management of a parapneumonic pleural effusion? |
| cord-009667-8r8j0h08 | one step forward with markers? |
| cord-009667-8r8j0h08 | when and why? |
| cord-300356-oorac5he | A meta- analysis Global and local epidemiology of community- acquired pneumonia: the experience of the CAPNETZ network Pneumonia: still the old man's friend? |
| cord-300356-oorac5he | Does this patient have community- acquired pneumonia? |
| cord-000237-mticfoic | ( a3Â1998,2007t5å? |
| cord-000237-mticfoic | ( t¿1997,2006t5å? |
| cord-000237-mticfoic | (? åºÅ¡AEHÄ÷). |
| cord-308916-6p2qutc5 | GAVI, the vaccine alliance World Health Organization perspectives on the contribution of the global alliance for vaccines and immunization on reducing child mortality Maternal immunization Effectiveness of maternal influenza immunization in mothers and infants Influenza vaccination of pregnant women and protection of their infants Duration of infant protection against influenza illness conferred by maternal immunization: secondary analysis of a randomized clinical trial Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality? |
| cord-308916-6p2qutc5 | Should ultrasound be included in the initial assessment of respiratory patients? |
| cord-308916-6p2qutc5 | what works and at what cost? |
| cord-016498-j72vrvqf | : a meta- analysis Is higher viral load in the upper respiratory tract associated with severe pneumonia? |
| cord-016498-j72vrvqf | How can we interpret these studies utilizing comprehensive molecular methods for etiology diagnosis of CAP? |
| cord-016498-j72vrvqf | What is the best therapy for influenza and viral causes of communityacquired pneumonia? |
| cord-016498-j72vrvqf | What is the role of respiratory viruses in community- acquired pneumonia in ambulatory pneumonia? |
| cord-283667-jqlz7yt8 | How reliable is a negative blood culture result? |
| cord-283667-jqlz7yt8 | Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States Mycoplasma pneumoniae infections- does treatment help? |
| cord-003291-zuqx6ksy | Does delivery improve maternal condition in the respiratory- compromised gravida? |
| cord-003291-zuqx6ksy | The Journal of maternal- fetal medicine Is ethnicity a risk factor for developing preeclampsia? |
| cord-312266-hnbgaxft | >/= 60 years: 3 years of follow- up in the CAPAMIS study 23-valent pneumococcal polysaccharide vaccine( PPV23) for the prevention of invasive pneumococcal diseases( IPDs) in the elderly: is it really effective? |
| cord-312266-hnbgaxft | what works and at what cost? |
| cord-010018-gl8uuqej | : when gold is bronze Antibiotic therapy for pediatric community- acquired pneumonia: do we know when, what and for how long to treat? |
| cord-010018-gl8uuqej | Does this child have pneumonia?: the rational clinical examination systematic review |
| cord-018408-ttae193b | prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? |
| cord-334470-tg8yqzrt | : Could it be useful today? |
| cord-334470-tg8yqzrt | authors: Kirkby, Charles; Mackenzie, Marc title: Is low dose radiation therapy a potential treatment for COVID-19 pneumonia? |
| cord-254852-qr5gdmbc | Does this infant have pneumonia? |
| cord-254852-qr5gdmbc | Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine( PPSV23) Vaccines for preventing pneumococcal infection in adults What is the best approach to the nonresponding patient with community- acquired pneumonia? |
| cord-317024-1rhzhpij | temos para o diagnóstico diferencial inicial entre pneumonia bacteriana e viral? |
| cord-266455-rbblg4pu | Evaluation and comprehensive analysis of the unyvero P50 pneumonia assay Assessment of the multiplex PCR- based assay unyvero pneumonia application for detection of bacterial pathogens and antibiotic resistance genes in children and Evaluation of Curetis unyvero, a multiplex PCR- based testing system, for rapid detection of bacteria and antibiotic resistance and impact of the assay on management of severe nosocomial pneumonia Sample- in, answer- out'? |
| cord-266455-rbblg4pu | severe hospital- acquired pneumonia( HAP) Comparison of unyvero P55 pneumonia cartridge, inhouse PCR and culture for the identification of respiratory pathogens and antibiotic resistance in bronchoalveolar lavage fluids in the critical care setting n Sample- in, answer- out'? |
| cord-273096-pgda7i3u | What Study Should Be Conducted Next? |
| cord-322104-f1dukpso | Microbiology of severe aspiration pneumonia in institutionalized elderly Validation of predictive rules and indices of severity for community acquired pneumonia Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance Antimicrobial therapy of community- acquired pneumonia A prediction rule to identify low- risk patients with community- acquired pneumonia Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community- acquried pneumonia Empiric antibiotic therapy and mortality among Medicare pneumonia inpatients in 10 Western states Pneumonia: still the old man's friend? |
| cord-315860-9j667c03 | What is the seasonal distribution of community acquired pneumonia over time? |
| cord-016521-ouwwkxox | : potential economic implications Is continuous subglottic suctioning cost- effective for the prevention of ventilator- associated pneumonia? |
| cord-016521-ouwwkxox | Does deescalation of antibiotic therapy for ventilatorassociated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? |
| cord-016521-ouwwkxox | Does this patient have ventilator- associated pneumonia? |
| cord-016521-ouwwkxox | Ventilator- associated pneumonia: is zero possible? |
| cord-307638-fffjcnak | : what do clinicians need to know? |
| cord-307638-fffjcnak | Grant Waterer, MBBS, PhD School of Medicine, University of Western Australia, Perth, WA, Australia Epidemiology: a mortal foe Recent controversies about MDR and XDR- TB: global implementation of the WHO shorter MDR- TB regimen and bedaquiline for all with MDR- TB? |
| cord-004464-nml9kqiu | How can it be that AI or machine- learning predictive algorithms that can already automatically drive cars or successfully understand human speech failed to predict the microbial cause of pneumonia accurately? |
| cord-004464-nml9kqiu | Predicting the microbial cause of community- acquired pneumonia: can physicians or a data- driven method differentiate viral from bacterial pneumonia at patient presentation? |
| cord-004464-nml9kqiu | The aim of our study was to evaluate and compare the abilities of experienced physicians and a data- driven approach to answer this simple question within the first hours of a patient's admission to the ICU for CAP: is it a viral or a bacterial pneumonia? |
| cord-004464-nml9kqiu | The clinicians had to answer the question: is it a viral or a bacterial pneumonia? |
| cord-004464-nml9kqiu | The first time point of this organized approach requires the physician to ask:"Does this patient have an infection that requires antibiotics?". |
| cord-004464-nml9kqiu | We aimed to evaluate the abilities of experienced physicians and AI to answer this question at patient admission: is it a viral or a bacterial pneumonia? |
| cord-004464-nml9kqiu | We demonstrated that experienced clinicians synthesizing all this information failed to adequately answer the question:"is it a viral or a bacterial pneumonia?", as the discriminant ability between the two diagnoses was considered low. |
| cord-004464-nml9kqiu | a systematic analysis for the global burden of disease study 2010 Ten- year trends in intensive care admissions for respiratory infections in the elderly Use of tracheal aspirate culture in newly intubated patients with community- onset pneumonia Data- driving methods: more than merely trendy buzzwords? |
| cord-288305-qt2a4pxs | 3) Was the child treated after the occurrence of pneumonia in a hospital for a respiratory illness? |
| cord-288305-qt2a4pxs | 4) Has the child had asthma diagnosed by a physician? |
| cord-288305-qt2a4pxs | 5) Has the child received any asthma treatment for difficulty in breathing during the past 12 months? |
| cord-288305-qt2a4pxs | 6) Has the child coughed for longer than 4 weeks at any time? |
| cord-288305-qt2a4pxs | Can we predict which children with clinically suspected pneumonia will have the presence of focal infiltrates on chest radiographs? |
| cord-288305-qt2a4pxs | If so, where was the diagnosis made and was it based on a chest radiograph? |
| cord-288305-qt2a4pxs | The questions were: 1) Has the child had bouts of pneumonia? 2) |
| cord-017252-88b3preq | : what is the most accurate combination? |
| cord-017252-88b3preq | What's new? |
| cord-017252-88b3preq | leukemia Frequent and prolonged shedding of bocavirus in young children attending daycare Human bocavirus: passenger or pathogen in acute respiratory tract infections? |
| cord-017252-88b3preq | what's old? |
| cord-320438-9j41eyw3 | Slovis TL( ed) Caffey's pediatric diagnostic imaging, 11th edn Thoracic disease in children with AIDS Viral vs. bacterial pulmonary infections in children( is roentgenographic differentiation possible?) |
| cord-320438-9j41eyw3 | where do we go now? |
| cord-023942-vrs3je1x | Do bronchodilators have an effect on bronchiolitis? |
| cord-023942-vrs3je1x | Does VATS provide optimal treatment of empyema in children? |
| cord-023942-vrs3je1x | Palivizumab is indicated for which of the following children? |
| cord-023942-vrs3je1x | Which of the following therapies have been proven to be a consistent benefi t for RSV bronchiolitis? |
| cord-310840-h49dx92d | The role of advanced imaging techniques in cystic fibrosis follow- up: is there a place for MRI? |
| cord-310840-h49dx92d | What imaging should we perform for the diagnosis and management of pulmonary infections? |
| cord-275828-c6d6nk7x | How common is human toxocariasis? |
| cord-275828-c6d6nk7x | How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community- acquired pneumonia? |
| cord-275828-c6d6nk7x | How much isoniazid is needed for prevention of tuberculosis among immune competent adults? |
| cord-275828-c6d6nk7x | Is bacterial tracheitis changing? |
| cord-275828-c6d6nk7x | What is health- care associated pneumonia, and how should it be treated? |
| cord-305786-06dpjik8 | A prediction rule to identify low- risk patients with community- acquired pneumonia Pneumonia in neonates: can it be managed in the community? |
| cord-305786-06dpjik8 | CT and pathologic examination findings MR imaging of pneumonia in immunocompromised patients: comparison with helical CT Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates Lung biopsy in immunocompromised children: when, how, and who? |
| cord-305786-06dpjik8 | a prospective observational study Initial microbiologic studies did not affect outcome in adults hospitalized with community- acquired pneumonia Utility of blood cultures in pediatric patients found to have pneumonia in the emergency department Nonvalue of the initial microbiological studies in the management of nonsevere community- acquired pneumonia Rejection criteria for endotracheal aspirates from adults Evaluation of rapid assay for detection of Streptococcus pneumoniae urinary antigen among infants and young children with possible invasive pneumococcal disease Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients Is a chest radiograph necessary in the evaluation of every febrile infant less than 8 weeks of age? |
| cord-016990-ot1wi3xi | : a review of ten years'experience Pulmonary complications of solid organ and hematopoietic stem cell transplantation Lungs are a major organ site of cytomegalovirus latency and recurrence Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome Cytomegalovirus- induced alveolar hemorrhage in patients with AIDS: a new clinical entity? |
| cord-016990-ot1wi3xi | How do viral infections predispose patients to bacterial infections? |
| cord-323742-rt0g0ufe | The effect of antibiotic exposure and specimen volume on the detection of bacterial pathogens in children with pneumonia Is higher viral load in the upper respiratory tract associated with severe pneumonia? |
| cord-323742-rt0g0ufe | lessons learned one year on Diagnostic test accuracy of a 2-transcript host RNA signature for discriminating bacterial vs viral infection in febrile children Should controls with respiratory symptoms be excluded from case- control studies of pneumonia etiology? |
| cord-017016-twwa9djm | 366 Abnormalities in sperm flagella may differ in type and quantity from those of respiratory cilia within the same patient, suggesting separate genetic control of axone mal structures at differing loci? |
| cord-017016-twwa9djm | 97 More recently the prognosis is much better, but the mortality associated with established abscess formation remains in the range of25%? |
| cord-017016-twwa9djm | A rare occurrence? |
| cord-017016-twwa9djm | A viral disease? |
| cord-017016-twwa9djm | Colonization or infection? |
| cord-017016-twwa9djm | Do nasal ciliary changes reflect bronchial changes? |
| cord-017016-twwa9djm | Lung abscess Should fiberoptic bronchoscopy aspirates be cultured? |
| cord-017016-twwa9djm | Screening Young syndrome patients for CFTR mutations Respiratory tract disease and obstructive azoospermia Ciliary function in Young's syndrome Rutland I Mucociliary function, ciliary ultrastructure, and ciliary orientation in Young's syndrome Measurement of nasal potential difference in adult cystic fibrosis, Young's syndrome and bronchiectasis Viscoelastic properties of sputum from patients with Young's Syndrome Was Young's syndrome caused by exposure to mercury in childhood? |
| cord-017016-twwa9djm | The diagnostic criteria of TBM by CT scan are a tracheal diameter of greater than 3 cm( measured 2 cm above the aortic arch) and diameters of 2.4 and 2.3 cm for the right and left main bronchi, respectively.415Al? |
| cord-017016-twwa9djm | an uncommon cause of neonatal respiratory distress? |
| cord-345211-4ivqlsgt | First, is a particular microorganism present in the clinical specimen? |
| cord-345211-4ivqlsgt | Second, if the microorganism is present, is it causing this episode of pneumonia? |
| cord-345211-4ivqlsgt | What are the limitations of molecular diagnostic tests for pneumonia and what needs to be addressed in order to progress with development? |
| cord-345211-4ivqlsgt | Why is it so difficult to determine the microbial etiology of pneumonia? |
| cord-007564-ljqrxjvv | How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community- acquired pneumonia? |
| cord-007564-ljqrxjvv | La première question concerne le diagnostic même de la PAC: le diagnostic étiologique est- il nécessaire au diagnostic positif de PAC? |
| cord-007564-ljqrxjvv | Quel est l'impact d'une donnée microbiologique positive sur la prise en charge des patients? |
| cord-007564-ljqrxjvv | Quel est l'impact pronostique de l'antibiothérapie? |
| cord-007564-ljqrxjvv | Update of practice guidelines for the management of community- acquired pneumonia in immunocompetent adults update of BTS pneumonia guidelines: what's new? |
| cord-007564-ljqrxjvv | chez un alcoolique, fumeur, bronchopathe, de 55 ans? |
| cord-007564-ljqrxjvv | concernant la prise en charge des PAC pneumococciques bactériémiques( mono- ou bithérapie?) |
| cord-007564-ljqrxjvv | d'envisager la stratégie d'utilisation des diverses techniques microbiologiques sous un angle plus général pour tenter de répondre aux questions suivantes: • quel est l'impact d'une recherche étiologique sur le pronostic des patients? |
| cord-005692-n4vxazst | Does this patient have VAP? |
| cord-005692-n4vxazst | Does this patient have ventilator- associated pneumonia? |
| cord-005692-n4vxazst | High prevalence of multidrugresistant nonfermenters in hospital- acquired pneumonia in Asia High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator- associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial Incidence and outcome of polymicrobial ventilator- associated pneumonia Antibiotic treatment of hospital- acquired pneumonia: is it different from ventilator- associated pneumonia? |
| cord-005692-n4vxazst | If invasive quantitative cultures are performed, should patients with suspected VAP whose culture results are below the diagnostic threshold for VAP( PSB with< 10 3 CFU/ mL, BAL with< 10 4 CFU/ mL) have their antibiotics withheld rather than continued? |
| cord-005692-n4vxazst | Nosocomial pneumonia in the intensive care unit acquired during mechanical ventilation or not Epidemiology and outcomes of ventilator- associated pneumonia in a large US database Ventilator- associated pneumonia( VAP) with multidrug- resistant( MDR) pathogens: optimal treatment? |
| cord-005692-n4vxazst | Oral care with chlorhexidine and stress ulcer prophylaxis may be harmful, new data affirm the long- held fear that selective oral and Should patients with suspected VAP be treated based on the results of invasive sampling( BAL, PSB, blind mini- BAL) with quantitative culture results, noninvasive sampling( endotracheal aspiration) with quantitative culture results, or noninvasive sampling with semiquantitative culture results? |
| cord-005692-n4vxazst | a hospital- wide, observational cohort study Protocol for a multi- centered, stepped wedge, cluster randomized controlled trial of the de- adoption of oral chlorhexidine prophylaxis and implementation of an oral care bundle for mechanically ventilated critically ill patients: the CHORAL study What US hospitals are currently doing to prevent common device- associated infections: results from a national survey Infection prevention practices in Japan, Thailand, and the United States: results from national surveys Semi- recumbent position versus supine position for the prevention of ventilatorassociated pneumonia in adults requiring mechanical ventilation Randomized, multicenter trial of lateral Trendelenburg versus semirecumbent body position for the prevention of ventilator- associated pneumonia Which multicenter randomized controlled trials in critical care medicine have shown reduced mortality? |
| cord-027678-k64whepc | : how do they differ from those in seasonal influenza? |
| cord-027678-k64whepc | Are there host factors that explain the failure( e.g. obstruction of bronchus by a foreign body or tumour, inadequate host response)? |
| cord-027678-k64whepc | Are there other organisms? |
| cord-027678-k64whepc | Has a complication developed( e.g. empyema, superinfection, bronchiolitis obliterans organising pneumonia, metastatic abscess)? |
| cord-027678-k64whepc | Has the patient got pneumonia? |
| cord-027678-k64whepc | Is the fever a drug fever? |
| cord-027678-k64whepc | Is the organism resistant to the drug being given? |
| cord-027678-k64whepc | Is the right drug being given in an adequate dose by the right route? |
| cord-027678-k64whepc | re-)bronchoscopy( is the diagnosis correct?), treat co- pathogens and consider a short course of high- dose i.v. methylprednisolone Fungi are rare but important causes of pneumonia. |
| cord-291400-o9skj94r | Are there interactions between the two antibiotics against Streptococcus pneumoniae? |
| cord-291400-o9skj94r | Bacteremic and nonbacteremic pneumococcal pneumonia: a prospective study Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community- acquired pneumonia Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community- acquired pneumonia in Spain Deaths in bacteremic pneumococcal pneumonia: a comparison of two populations Bacteremic pneumococcal pneumonia mortality rate: is it really different in Sweden? |
| cord-291400-o9skj94r | Correlation with in vitro resistance, antibiotics administered, and clinical outcome Is azithromycin the first- choice macrolide for treatment of community- acquired pneumonia? |
| cord-291400-o9skj94r | Is anti- tumor necrosis factor therapy associated with increased mortality in patients with severe sepsis caused by pneumonia? |
| cord-291400-o9skj94r | The best treatment of pneumonia: new clues, but no definitive answers What is optimal therapy for bacteremic pneumococcal pneumonia? |
| cord-291400-o9skj94r | What is needed in the future? |
| cord-291400-o9skj94r | What is the possibility that the immune- modulating activity of macrolides is important in reducing the mortality rate? |
| cord-291400-o9skj94r | What is the possibility that the macrolide is treating a secondary infection in a patient with pneumococcal bacteremia? |
| cord-291400-o9skj94r | Why do some countries have many cases of nosocomial S pneumoniae infections[ 7] and others( eg, the United States) have a minimal number of such cases[ 27]? |
| cord-291400-o9skj94r | Why does the CFR differ among different centers and countries[ 40, 41]? |
| cord-291400-o9skj94r | Why would a b- lactam( cephalosporin) in combination with a macrolide be more efficacious than a b- lactam( cephalosporin) alone in the treatment of patients with bacteremic pneumococcal pneumonia? |
| cord-291400-o9skj94r | Would the use of two empiric antibiotics make it more likely that at least one would be active against the pneumococcus? |
| cord-292094-vmsdhccp | : a meta- analysis Is the lateral decubitus radiograph necessary for the management of a parapneumonic pleural effusion? |
| cord-292094-vmsdhccp | A framework for improvement Do guidelines for community- acquired pneumonia improve the cost- effectiveness of hospital care? |
| cord-292094-vmsdhccp | How should we make the admission decision in community- acquired pneumonia? |
| cord-292094-vmsdhccp | Predicting bacteremia in patients with community- acquired pneumonia Diagnosing pneumonia by physical examination: relevant or relic? |
| cord-292094-vmsdhccp | The burden of community- acquired pneumonia in seniors: results of a population- based study Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995- 1997 Guidelines for community- acquired pneumonia: are they reflected in practice? |
| cord-292094-vmsdhccp | What factors influence physicians'decisions to switch from intravenous to oral antibiotics for community- acquired pneumonia? |
| cord-292094-vmsdhccp | Why do n't physicians follow clinical practice guidelines? |
| cord-292094-vmsdhccp | an international derivation and validation study Community- acquired pneumonia requiring hospitalization: 5-year prospective study outcome and prognostic factors in community- acquired pneumonia requiring hospitalization Appropriateness of hospitalization of patients with community- acquired pneumonia Assessing prognosis and selecting an initial site of care for adults with community- acquired pneumonia Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial Community acquired pneumonia: aetiology and usefulness of severity criteria on admission Use of prognostic scoring and outcome assessment tools in the admission decision for community- acquired pneumonia Assessment of illness severity in community acquired pneumonia: a useful new prediction tool? |
| cord-292094-vmsdhccp | analysis of two double- blind studies of patients with methicillin- resistant Staphylococcus aureus nosocomial pneumonia Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression American Thoracic Society/ Centers for Disease Control and Prevention/ Infectious Diseases Society of America: controlling tuberculosis in the United States Anti- inflammatory effects of macrolides- an underappreciated benefit in the treatment of community- acquired respiratory tract infections and chronic inflammatory pulmonary conditions? |
| cord-292094-vmsdhccp | implications for the treatment of patients with community- acquired pneumonia Streptococcus pneumoniae in community- acquired pneumonia: how important is drug resistance? |
| cord-008695-y7il3hyb | ( neuraminidase inhibitors) during a pandemic? |
| cord-008695-y7il3hyb | Airway hyperreactivity and peripheral airway dysfunction in influenza A infection American College of Chest Physicians/ National Heart, Lung, and Blood Institute National Conference on Oxygen Therapy Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia Pandemic influenza: is an antiviral response realistic? |
| cord-008695-y7il3hyb | Antibiotic choice for severe or complicated pneumonia? |
| cord-008695-y7il3hyb | Does this patient have influenza? |
| cord-008695-y7il3hyb | For how long should antibiotics be given? |
| cord-008695-y7il3hyb | The impact of influenza epidemics on mortality: introducing a severity index Human influenza Principles and Practice of Clinical Virology Clinical features of influenza Age and Asian influenza, 1957 Rapid diagnosis of primary influenza pneumonia Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A Should staff in long- stay hospitals for elderly patients be vaccinated against influenza? |
| cord-008695-y7il3hyb | What are the optimum antibiotic choices when specific pathogens have been identified? |
| cord-008695-y7il3hyb | What drugs should be used for antiviral treatment during a pandemic? |
| cord-008695-y7il3hyb | What general investigations should be done in the community? |
| cord-008695-y7il3hyb | What monitoring should be conducted during a hospital stay? |
| cord-008695-y7il3hyb | What severity assessment strategy is recommended for patients referred to hospital with influenzarelated pneumonia? |
| cord-008695-y7il3hyb | When can children be safely discharged from hospital? |
| cord-008695-y7il3hyb | When should the IV route be changed to oral? |
| cord-008695-y7il3hyb | When should transfer to a high dependency unit( HDU) or intensive care unit( ICU) be considered? |
| cord-008695-y7il3hyb | Which adults require hospital referral? |
| cord-008695-y7il3hyb | Who should get antibiotics? |
| cord-008695-y7il3hyb | Who should receive antiviral drugs? |
| cord-021951-xxvol17t | Are there older siblings with cystic fibrosis( CF) or asthma? |
| cord-021951-xxvol17t | Can the child be calmed or engaged in play? |
| cord-021951-xxvol17t | Did the child have RSV, bronchiolitis, or rhinovirus infection as an infant? |
| cord-021951-xxvol17t | Did the child receive a bone marrow transplant a year ago? |
| cord-021951-xxvol17t | Did the infant have a tracheoesophageal fistula repaired in the neonatal period? |
| cord-021951-xxvol17t | Did the toddler choke on a carrot or other food 3 months ago? |
| cord-021951-xxvol17t | Does the child appear wasted, with poor growth that may indicate a chronic illness? |
| cord-021951-xxvol17t | Does the child have an anxious look? |
| cord-021951-xxvol17t | Does the examining room or the clothing smell of stale cigarette smoke? |
| cord-021951-xxvol17t | Does the patient look"barrel- chested"? |
| cord-021951-xxvol17t | Does this patient have sinusitis? |
| cord-021951-xxvol17t | Is the anteroposterior( AP) diameter increased, which indicates hyperinflation of the lungs from obstruction of small airways( asthma, bronchiolitis, CF)? |
| cord-021951-xxvol17t | Is the child immunized? |
| cord-021951-xxvol17t | Is the child's breath malodorous, as can be noticed in sinusitis, nasal foreign body, lung abscess, or bronchiectasis? |
| cord-021951-xxvol17t | Is the child's skin blue( representing cyanosis) or ashen? |
| cord-021951-xxvol17t | Is there a coughing sibling whose kindergarten class has been closed because of pertussis? |
| cord-021951-xxvol17t | Is there a foul odor from a diaper with a fatty stool, which may suggest pancreatic insufficiency and CF? |
| cord-021951-xxvol17t | Is there an adolescent or adult with chronic cough( bronchitis) who may have pertussis or tuberculosis? |
| cord-021951-xxvol17t | Is this diameter small, as can be seen with some restrictive lung diseases with small lung volumes( muscular dystrophy, spinal muscular atrophy)? |
| cord-021951-xxvol17t | Radiographs usually show diffuse fluffy Postnasal drip(?) |
| cord-021951-xxvol17t | Was the child premature, and, if so, did he or she spend a month on the ventilator, and does he or she now have chronic lung disease( bronchopulmonary dysplasia)? |
| cord-021951-xxvol17t | • Is the child struggling to breathe( dyspnea)? |
| cord-009278-98ebmd33 | Adjunctive therapies Which patients will benefit from steroid therapy in CAP? |
| cord-009278-98ebmd33 | Can steroids and macrolides have an addictive anti- inflammatory effect? |
| cord-009278-98ebmd33 | Could PK/ PD interventions change the outcomes in severe CAP? |
| cord-009278-98ebmd33 | How should microbiologic surveillance be performed in a global way? |
| cord-009278-98ebmd33 | How should viral infection be excluded before steroid treatment? |
| cord-009278-98ebmd33 | In non- severe CAP might new oral antibiotics be directed to once- daily dosages? |
| cord-009278-98ebmd33 | In patients with CAP presenting with high inflammatory response, can steroid therapy improve hard outcomes? |
| cord-009278-98ebmd33 | In severe CAP what is the best drug on top of beta- lactam therapy: macrolide or quinolone? |
| cord-009278-98ebmd33 | Is PCV13 superior to PPV23 in invasive pneumococcal disease and pneumococcal CAP? |
| cord-009278-98ebmd33 | Is adult pneumococcal vaccination cost- effective in settings with high childhood vaccination rates? |
| cord-009278-98ebmd33 | Is vaccine efficacy equivalent in immunocompetent and immunosuppressed patients? |
| cord-009278-98ebmd33 | Should antiviral therapy be used empirically during influenza seasonal epidemics or all year? |
| cord-009278-98ebmd33 | What are the best steroid, steroid dose and duration in CAP? |
| cord-009278-98ebmd33 | What is the real burden of morbidity and mortality after CAP? |
| cord-009278-98ebmd33 | What is the role of tetracyclines in CAP treatment? |
| cord-009278-98ebmd33 | Which is the best scheme/ schedule of anti- pneumococcal vaccination? |
| cord-009278-98ebmd33 | Which is the epidemiology of lethal CAP? |
| cord-009278-98ebmd33 | Which patients should be treated with antiviral therapy in CAP? |
| cord-009278-98ebmd33 | Why is evidence of short duration antibiotic therapy in CAP not applied in clinical management? |
| cord-009278-98ebmd33 | Will vaccines directed to S. pneumoniae virulence factors be more efficient than current ones? |